Jane Street’s Psyence Biomedical PBM Stock Holding History
Bought
Maintained
Sold
Other funds holding PBM
Jane Street's PBM Position: Q3 2026 in Review
Jane Street reduced its Psyence Biomedical (PBM) stake by 47% in Q3 2026, selling an estimated $58.1K and leaving 16,240 shares worth $88.7K. The position accounts for ﹤0.01% of the portfolio, ranked #10679.
Jane Street first reported a position in PBM in Q3 2024 and has held it in 3 quarters since. The position peaked at $93.1K in Q2 2026. 10 funds tracked by Wall St. Rank hold PBM as of Q3 2026.
- Jane Street held 16,240 shares of Psyence Biomedical worth $88.7K as of Q3 2026.
- Jane Street sold 14,191 Psyence Biomedical shares in Q3 2026, an estimated $58.1K.
- Psyence Biomedical made up ﹤0.01% of Jane Street's portfolio in Q3 2026, its #10679 holding.
- Jane Street first reported a position in Psyence Biomedical in Q3 2024 and has held it in 3 quarters since.
- Jane Street's Psyence Biomedical position peaked at $93.1K in Q2 2026.
- 10 funds tracked by Wall St. Rank held Psyence Biomedical as of Q3 2026.
Based on Jane Street's 13F filing for Q3 2026, filed 12 Nov 2026.